| Listed site | cdmo | cdmo |
|---|
| Summary | Global CDMO offering development and manufacturing for protein expression biologics, pDNA, mRNA, viral vectors (AAV, LVV, RVV), and genetically engineered cells with scale-out manufacturing capabilities. | Leading global CDMO offering end-to-end development and manufacturing for pharma, biotech, and consumer health—spanning oral dose, biologics, cell and gene therapies, clinical supply, and specialty formulations with advanced technologies and worldwide GMP capacity. |
|---|
| Services | - Technology Transfer
- Process Development
- Cell-Line Development
- CMC Analytical Development
- Formulation Development
- Quality Control Testing
- Sterile Fill-Finish & Aseptic Manufacturing
- CMC Regulatory Submission Support
- Recombinant Protein Manufacturing
- Monoclonal Antibody (mAb) Manufacturing
- Upstream Processing
- Downstream Processing
- Cell Therapy Manufacturing
- Viral Vector Manufacturing
- AAV Manufacturing
- Lentiviral Vector Manufacturing
- ADC (Antibody-Drug Conjugate) Manufacturing
- mRNA Manufacturing
- Biologics Development & Manufacturing
- Vial Filling
- Prefilled Syringe (PFS) Filling
| - Cell Therapy Manufacturing
- Viral Vector Manufacturing
- AAV Manufacturing
- Oral Solid Dosage Manufacturing
- Inhalation & Nasal Dosage Manufacturing
- Formulation Development
- Process Development
- CMC Analytical Development
- Technology Transfer
- Sterile Fill-Finish & Aseptic Manufacturing
- Quality Control Testing
- Recombinant Protein Manufacturing
- Biologics Development & Manufacturing
- API Synthesis & Manufacturing
- Small Molecule Development & Manufacturing
- Monoclonal Antibody (mAb) Manufacturing
- Secondary Packaging & Labeling
- Stability Testing & Storage
- CMC Regulatory Submission Support
- Cell-Line Development
- Upstream Processing
- Downstream Processing
- Vial Filling
- Prefilled Syringe (PFS) Filling
- Topical & Semi-Solid Manufacturing
- Serialization & Track-and-Trace
- Cold-Chain Storage & Logistics
- Cartridge Filling
- Lyophilization (Freeze Drying)
- Lentiviral Vector Manufacturing
|
|---|
| Modalities | - Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Cell Therapy
- Gene Therapy
- AAV / Viral Vector Platform
- mRNA
- Antibody-Drug Conjugate (ADC)
| - Small Molecule
- Biologics (Monoclonal Antibodies)
- Biologics (Other)
- Cell Therapy
- Gene Therapy
- AAV / Viral Vector Platform
|
|---|
| Indications | Data not yet provided. | Data not yet provided. |
|---|
| Locations | - Headquarters, Seattle, Washington, USA
- Copenhagen, Copenhagen, Denmark
- Heidelberg, Heidelberg, Germany
- Milan, Milan, Italy
- Chiba, Chiba, Japan
- Yokohama, Yokohama, Japan
| - Headquarters, United States
- Asia Pacific, Asia Pacific
- Europe, Europe
- Latin America, Latin America
- North America, North America, United States
- China, China
- Japan, Japan
- North America, North America
- Global Network
|
|---|
| Certifications | Data not yet provided. | - GMP · Identifier: Nine GMP facilities
|
|---|
| Reviews | Review summary appears after site-level review signal gate opens. | Review summary appears after site-level review signal gate opens. |
|---|